Methods: Phenotypes were measured within age-matched male DO mice (n=338) and the 5 common [A/J (n=6), C57BL/6J (n=14), 129S1/ SvlmJ (n=6), NOD/LtJ (n=6), NZO/H1LtJ (n=6)] and 3 wild-derived [CAST/EIJ (n=8), PWK/PHJ (n=8), WSB/EIJ (n=6)] inbred founders. A sleep definition of ≥40 seconds of continuous inactivity using infrared beams was utilized to quantify sleep/wake amounts and bout characteristics in light and dark phases. Latency to sleep (vigilance), multiple sleep latency test (MSLT), response to sleep deprivation, and circadian period (using wheel running) were also estimated. Reproducibility was calculated using Intraclass Correlation Coefficients (ICCs) from repeated assessments. Narrow-sense heritability (h 2 ) was calculated as the proportion of variability explained by additive genetic effects using genotype data in DO mice, and broad-sense heritability (H 2 ) calculated as the proportion of variability explained by genotype in founders. Results: Most phenotypes were reproducible within individual mice, with ICC≥0.60. Sleep and wake phenotypes using alternative definitions of ≥20, ≥60 or ≥80 seconds of inactivity were highly correlated (ρ>0.85) with primary measures (≥40 seconds), demonstrating the robustness of the sleep definition. Differences in all traits were seen between founder strains and there was moderate-high heritability for most phenotypes; sleep/wake characteristics during lights-off and circadian period were the most heritable (H 2 =54-60%). There was large phenotypic variability among DO mice; values covered and extended beyond the range across founders. Estimates of heritability were lower in DO mice than in founders, with circadian period the most heritable (h 2 =36%). This may reflect unmeasured non-additive genetic effects. Conclusion: A high-throughput phenotyping strategy based on monitoring of activity patterns in mice provides reproducible estimates of sleep and circadian characteristics with evidence of heritability. This paradigm is suitable for use in DO mice, where genetic factors explain some proportion of phenotypic variability. Support (If Any): NIH grant R01 HL111725. Introduction: While the concept of 'sleep health' has only recently been defined, how it relates to both subjective and objective sleep parameters has yet to be determined. The current study aimed to identify potential sleep (subjective and objective) markers of sleep health in a sample of healthy adults. Methods: A cross-sectional study with both a questionnaire-based and an in-lab component was conducted with eighty-three 'normal sleepers' (aged 18-65). All participants reported no history of insomnia, any other sleep disorders or chronic physical or psychiatric illnesses. A selection of questions from various psychometric scales were used to determine sleep health status. Measures of psychological distress, perceived stress, stressful life events, sleep beliefs, sleep preoccupation and insomnia vulnerability were also administered. Subjective sleep continuity was assessed by two-week sleep diary. Objective measures comprised 14 days of actigraphy and two-nights of in-lab polysomnography (PSG). Results: Significant correlations were found between sleep health status and subjective Sleep Efficiency (diary) and Sleep Latency (from both diary and actigraphy). Independent samples t-tests between high and low sleep health groups reflected this. No relationships between sleep health and PSG parameters were not observed. Regression analyses indicated SOL (diary) and SOL (actigraphy) were significant predictors of sleep health, explaining 24.9% of the variance in scores. Conclusion: Sleep health is likely to be a largely subjective and multidimensional concept, which may be predicted by perceived sleep latency and sleep efficiency. However, it is suggested that PSG sleep parameters cannot reliably infer sleep health status in normal sleepers. Future research is warranted to determine the dimensionality of the concept, and the physical and psychological correlates of sleep health in larger samples. Support (If Any): This study was funded by The Sleep Council. 
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DISTINCT PATTERNS OF EEG-EMG-COHERENCE IN VARIOUS STAGES OF DISEASE SEVERITY IN PATIENTS WITH SLEEP-DISORDERED BREATHING
Introduction:
We investigated whether using EEG-EMG-coherence (EEC) as a feature fed to a support vector machine (SVM) algorithm may allow staging of disease severity among sleep-disordered-breathing (SDB) patients. Methods: EEG-EMG-coherence data resulted by applying a multitaper processing for estimating the power spectrums separately and calculating the coherence on raw C3-/C4-EEG-and EMG-chin data of polysomnographic (PSG) recordings of 102 SDB patients (33 female; age: 53, ± 12,4 yrs) acquired on two consecutive nights in each patient. Four epochs (30 seconds each, classified manually by AASM 2012-criteria) of each sleep stage were marked (in total 1632 epochs / night) and were included in the analysis. After multitaper processing, EEC values were fed to a SVM algorithm to classify SDB disease severity based on respiratory disturbance index (RDI). Twenty patients had a mild (RDI ≥ 10 / h and <15 / h), 30 patients had a moderate (RDI ≥ 15 / h and <30 / h) and 27 patients had a severe OSA (RDI ≥ 30 / h). Twenty five patients had a RDI <10 / h. The AUC (area under the curve) value was calculated for each receiver operator characteristic (ROC) curve. Results: EEG-EMG coherence values could distinguish between SDB-patients without OSA and OSA patients of the above three severity groups using an SVM algorithm. Using PSG data of the first night the AUC for mild OSA was 0.602 (p = 0.032), in moderate OSA the AUC was 0.6319 (p = 0.021), and in severe OSA the AUC was 0.823 (p <0.001). On the second night, in mild OSA the AUC was 0.616 (p = 0.024), in moderate OSA the AUC was 0.659 (p = 0.003), and in severe OSA the AUC was 0.823 (p <0.001). Conclusion: Grading disease severity in SDB patients can be performed using PSG-based multitaper-processed EEC values processed with a SVM algorithm. No clinically relevant first night-effect was shown in EEC values. EEG-EMG-coherence appears to be a robust marker for SDB severity classification. 
AUTOMATIC DETECTION OF RESPIRATORY EVENTS DURING SLEEP USING BIDIRECTIONAL LSTM NETWORKS
Methods:
In order to validate the actigraphy and 24-hour ECG recording 500 patients referred to polysomnography in a sleep center are equipped in parallel with actigraphy (one on the wrist and one on the hip) and a single-lead 24-hour ECG. For actigraphy on the wrist a Somnowatch plus (128 Hz sampling) with 3D acceleration was used. For actigraphy on the hip a GT3X+, primarily applied for estimating energy consumption, was used. ECG was analyzed for heart rate variability and electrocardiographic derived respiration (EDR) for all slep stages. Actigraphy was analyzed for threshold passing and in addition with spectral analysis in 30-second epochs in parallel with PSG sleep scorings.
Results:
The validation study has now completed 155 patients. Mean age of subjects is 45.7 years. Mean AHI in this sleep center population was 12 /hour. Analysis of cyclical variation of heart rate and EDR allows to detect sleep apnea events from single-lead ECG recordings. In addition, it was possible to detect respiration from high resolution actigraphy both from wrist and hip placed devices by applying a frequency analysis on 30-second epochs. Dection of respration is best for stage N3.
Conclusion:
The surprising result showed that actigraphy allowed to detect respiration with high accuracy during sleep and during periods with low activity. With this it appears possible to detect apnea events as well. To validate apnea recognition more subjects with apnea are needed. If successful this will allow to improve ECG based apnea detection and will allow to apply simple recording technology on really large epidemiological cohort studies to check prevalence in unselected groups of subjects. 
